340 related articles for article (PubMed ID: 9380220)
1. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
[No Abstract] [Full Text] [Related]
2. [A short history of beta-interferon therapy of multiple sclerosis].
Stock G; Horowski R
Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects].
Walther EU; Dietrich E; Hohlfeld R
Nervenarzt; 1996 Jun; 67(6):452-6. PubMed ID: 8767199
[TBL] [Abstract][Full Text] [Related]
4. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland].
Huber S; Spycher M; Lechner-Scott J; Bellaiche Y; Steck AJ; Kappos L
Schweiz Med Wochenschr; 1996 Aug; 126(35):1475-81. PubMed ID: 8927950
[TBL] [Abstract][Full Text] [Related]
5. Treatment of multiple sclerosis with interferon beta 1b.
Dhib-Jalbut S; McFarland HF
Baillieres Clin Neurol; 1997 Oct; 6(3):467-80. PubMed ID: 10101584
[TBL] [Abstract][Full Text] [Related]
6. [Interferon-beta in treatment of relapsing multiple sclerosis].
Hartung HP; Hohlfeld R
Nervenarzt; 1994 Feb; 65(2):139-45. PubMed ID: 8164769
[No Abstract] [Full Text] [Related]
7. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
de Haan RJ; Polman CH
Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2168-71. PubMed ID: 8984352
[No Abstract] [Full Text] [Related]
8. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
9. [The role of interferon beta in the treatment of multiple sclerosis].
Seeldrayers P
Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902
[TBL] [Abstract][Full Text] [Related]
10. Early treatment.
Comi G
Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with beta-interferon should be started already after the first attack of MS].
Söderström M
Lakartidningen; 2001 Feb; 98(6):587-90, 593-4. PubMed ID: 11475246
[No Abstract] [Full Text] [Related]
12. New treatments for multiple sclerosis.
Hutchinson M
Ir Med J; 1996; 89(2):44. PubMed ID: 8682623
[No Abstract] [Full Text] [Related]
13. [Interferon therapy of multiple sclerosis].
Jensen D
Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
[TBL] [Abstract][Full Text] [Related]
14. Issues in pharmaceutical lotteries: the case of interferon beta-1b.
Manocchia M; Lasagna L
Clin Pharmacol Ther; 1997 Sep; 62(3):241-7. PubMed ID: 9333099
[No Abstract] [Full Text] [Related]
15. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ
Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030
[TBL] [Abstract][Full Text] [Related]
16. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418
[TBL] [Abstract][Full Text] [Related]
17. The treatment of multiple sclerosis with beta-interferon.
Poser CM
Neuroepidemiology; 2008; 31(3):157-8. PubMed ID: 18716413
[No Abstract] [Full Text] [Related]
18. Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations.
Bagnato F; Gupta S; Richert ND; Stone RD; Ohayon JM; Frank JA; McFarland HF
Arch Neurol; 2005 Nov; 62(11):1684-8. PubMed ID: 16157739
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of multiple sclerosis using recombinant interferon-beta].
Polman CH; Barkhof F; van Loenen AC; Lucas CJ; Koetsier JC
Ned Tijdschr Geneeskd; 1994 Jan; 138(1):7-10. PubMed ID: 8289963
[No Abstract] [Full Text] [Related]
20. [Interferon-beta 1B in the treatment of remittent-recurrent multiple sclerosis. Clinical experience of the Valencia group. Multiple sclerosis study group of the city of Valencia].
Rev Neurol; 1997 Dec; 25(148):1876-9. PubMed ID: 9528021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
